OpGen Inc (NASDAQ: OPGN) shares were ripping higher Monday in reaction to an announcement regarding a COVID-19 test kit from German molecular diagnostics company Curetis, which OpGen has agreed to merge with.Curetis said it has begun offering a CE-IVD-certified real-time PCR test kit for SARS-CoV-2, the virus causing COVID-19, OpGen said.The test kit, developed and manufactured by Curetis' Chinese strategic partner BGI, was cleared by the Chinese authorities in January. It was CE-IVD certified on Feb. 28. CE certification indicates the product is in conformity with health, safety and environmental protection standards for products sold in the European Economic Area.The BGI COVID-19 test kit allows labs to perform testing of nasopharyngeal swabs and bronchoalveolar lavage fluid. It has all necessary reagents and controls to test up to 48 patients in just a few hours, according to OpGen. The test is to be made available to labs in Europe through Curetis' network...
Ariel Investments Vice Chairman Charlie Bobrinskoy joins On The Move to discuss how the markets are responding to the coronavirus outbreak and why he is optimistic there will be a turn around in a month....
Disney is under scrutiny from investors with its stock under pressure as theme parks close and high-profile movie releases face delays. Bernie McTernan, Rosenblatt Securities Vice President, joins On The Move to discuss what Disney can do to turn things around in the midst of this pandemic....